Fabrication of drug-loaded edible carrier substrates from nanosuspensions by flexographic printing.

[1]  A. Noyes,et al.  The rate of solution of solid substances in their own solutions , 1897 .

[2]  N. Kaneniwa,et al.  Physicochemical characterization of indomethacin polymorphs and the transformation kinetics in ethanol. , 1985, Chemical & pharmaceutical bulletin.

[3]  Ron Jenkins,et al.  Introduction to X-ray powder diffractometry , 1996 .

[4]  R. Suryanarayanan,et al.  Identification of drugs in pharmaceutical dosage forms by X-ray powder diffractometry. , 1997, Journal of pharmaceutical and biomedical analysis.

[5]  Rainer H. Müller,et al.  Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique , 1998 .

[6]  C. Lipinski.  Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.

[7]  R. Müller,et al.  Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. , 2001, Advanced drug delivery reviews.

[8]  Jonghwi Lee.  Drug nano- and microparticles processed into solid dosage forms: physical properties. , 2003, Journal of pharmaceutical sciences.

[9]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[10]  S. Benita,et al.  Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[11]  Rainer H Müller,et al.  Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[12]  D. Hauss.  Oral lipid-based formulations. , 2007, Advanced drug delivery reviews.

[13]  L. Froyen,et al.  Microcrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions - a case study with itraconazole. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[14]  E. Merisko-Liversidge,et al.  Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds , 2008, Toxicologic pathology.

[15]  Patrick Augustijns,et al.  Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. , 2008, International journal of pharmaceutics.

[16]  L. Froyen,et al.  Drying of crystalline drug nanosuspensions-the importance of surface hydrophobicity on dissolution behavior upon redispersion. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[17]  S. Vaghani,et al.  Itraconazole nanosuspension for oral delivery: Formulation, characterization and in vitro comparison with marketed formulation , 2010, Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences.

[18]  M. Mazzotti,et al.  Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability. , 2010, International journal of pharmaceutics.

[19]  N. Blagden,et al.  Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[20]  I. Ghosh,et al.  Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth. , 2011, International journal of pharmaceutics.

[21]  Niklas Sandler,et al.  Inkjet printing of drug substances and use of porous substrates-towards individualized dosing. , 2011, Journal of pharmaceutical sciences.

[22]  Timo Laaksonen,et al.  Nanosuspensions of poorly soluble drugs: preparation and development by wet milling. , 2011, International journal of pharmaceutics.

[23]  A. Zimmer,et al.  Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines. , 2011, International journal of pharmaceutics.

[24]  G. Van den Mooter,et al.  Is the amorphous fraction of a dried nanosuspension caused by milling or by drying? A case study with Naproxen and Cinnarizine. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[25]  Nae-oh Chung,et al.  Mechanism of freeze-drying drug nanosuspensions. , 2012, International journal of pharmaceutics.

[26]  Niklas Sandler,et al.  Tailoring controlled-release oral dosage forms by combining inkjet and flexographic printing techniques. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[27]  Lin Li,et al.  Fabrication of quercetin nanocrystals: comparison of different methods. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[28]  Niklas Sandler,et al.  A step toward development of printable dosage forms for poorly soluble drugs. , 2013, Journal of pharmaceutical sciences.

[29]  Carlos E Figueroa,et al.  Spray granulation: importance of process parameters on in vitro and in vivo behavior of dried nanosuspensions. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  Indrajit Ghosh,et al.  Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[31]  Marco Mazzotti,et al.  Formulation and drying of miconazole and itraconazole nanosuspensions. , 2013, International journal of pharmaceutics.

[32]  Jörg Breitkreutz,et al.  Drug-printing by flexographic printing technology--a new manufacturing process for orodispersible films. , 2013, International journal of pharmaceutics.

[33]  Niklas Sandler,et al.  Behavior of printable formulations of loperamide and caffeine on different substrates--effect of print density in inkjet printing. , 2013, International journal of pharmaceutics.

[34]  K. Järvinen,et al.  Nanocrystal-based per-oral itraconazole delivery: superior in vitro dissolution enhancement versus Sporanox® is not realized in in vivo drug absorption. , 2014, Journal of controlled release : official journal of the Controlled Release Society.